the authors report.The finding gives a better understanding of the body processes underlying melanoma, which could eventually lead to better treatments. The Cdk4 gene has been known to be more ...

2) Overcoming chemotherapy resistance by a combination with immunotherapy in melanoma. Our preliminary data revealed that PD-1, an immune checkpoint protein, is involved in the resistance to one ...

Risks and benefits of genetic testing for CDKN2A mutations have not been extensively studied, although one European group recently examined reasons why those not participating in genetic testing ...